News

The new offering will connect athenahealth’s centrally hosted, web-based services, athenaClinicals and athenaCollector, with Microsoft Amalga, an enterprise health intelligence platform. By enabling the flow of data across

Clariant head of Global Market Segment Medical and Pharmaceutical Stephen Duckworth will head this sector-specific segment which will manage the development, production, marketing and technical support. MEVOPUR color

Quanterix CEO David Okrongly said they are excited to initiate this technology evaluation with Novartis, one of the world’s leading healthcare companies. "Through this collaborative project, we hope

The nCounter analysis system is a fully automated digital detection and counting system with a simple workflow which measures chromosome number and detect aneuploidy. Chief commercial officer Barney

Somatic hypermutation (SHM) is the body’s natural process for generating potent antibodies to fight disease. AnaptysBio’s SHM-XEL platform combines SHM with mammalian cell expression, secretion and display, deep

The two companies will provide over 10,000 cancer care professionals with early access to the latest panels of protein biomarkers implicated in different cancers. Avantra had announced the

ImmuPharma’s clinical trial began last summer and up to now two lower dose levels have been tested. The initial dose level of 1 mg/kg did not show any

The study is designed to provide additional data, if required, by the US Food and Drug Administration (FDA) for the approval of RHUCIN at the 50 U/kg dose.

The study results showed that TMC435 was safe and well-tolerated with no clinically relevant differences in adverse events between treatment groups and standard of care. In the treatment